← Back to Clinical Trials
Recruiting NCT06967792

NCT06967792 Evaluation of the Safety of Terahertz Scanning System on Corneas

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06967792
Status Recruiting
Phase
Sponsor Singapore Eye Research Institute
Condition Corneal Diseases
Study Type OBSERVATIONAL
Enrollment 5 participants
Start Date 2024-04-01
Primary Completion 2025-12-31

Trial Parameters

Condition Corneal Diseases
Sponsor Singapore Eye Research Institute
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2024-04-01
Completion 2025-12-31
Interventions
Terahertz (THz) scanning using THz Imaging system.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This observational study aims to establish the safety profile of the use of Terahertz (THz) scanning system on corneal diseases. Participants with "non-seeing" eyes but normal corneas will undergo THz scanning. Eye examinations will be conducted at baseline, immediately after scanning, and at 1 day, 1 week, and 1 month post-scanning. These examinations will include measurements of visual acuity, eye structural, retinal health, corneal cell morphology, and corneal nerve status. The investigators hypothesize that the THz scanning system is safe for application to the human cornea.

Eligibility Criteria

Inclusion Criteria: * Be at least 21 years of age * Regardless of gender (Male/Female) * Regardless of race (Chinese/Malay/Indian/Eurasian/Others) * Willingness and ability to follow all instructions and comply with study schedule for study visit * Have at least 1 eye (Study eye) that is deemed functionally blind but contain healthy corneas * Ability to hold face sufficiently stable to undergo necessary scans * Best Spectacle Corrected Visual Acuity (BSCVA) in the study eye of hand motion or worse Exclusion Criteria: * Pregnant/Breast-feeding women * Eyes with previous major surgery on the cornea such as corneal transplantation, refractive surgery, corneal cross-linking procedure * Eyes with previous infectious keratitis * Eyes with long-term use of glaucoma eye drops * Eyes with known moderate or server meibomian gland dysfunction * Eyes with active inflammation or infection, or chronic ocular surface inflammation * Systemic diseases that affect the ocular surface, such as systemic au

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology